A Case of X-Linked Sideroblastic Anemia Secondary to Hemochromatosis and Literature Review
-
摘要:
目的 分析和总结X连锁铁粒幼细胞性贫血继发血色病患者的病例资料。 方法 回顾性分析昆明医科大学第一附属医院内分泌一科收治的1例X连锁铁粒幼细胞性贫血继发血色病的临床资料,并复习相关文献。 结果 该患者因乏力反复就诊多家医院均未明确病因,后因高血糖、皮肤色素沉着收住昆明医科大学第一附属医院内分泌一科。经完善骨髓穿刺、基因检测、肝脏CT及MRI后明确诊断,给予去铁治疗后患者临床症状改善。后因患者未规律去铁治疗,最终死于心衰。 结论 血色病引起的糖尿病是1种特殊类型的糖尿病,其诊断除依靠血清学、影像学检查外,基因学检查也非常重要。临床上当发现皮肤色素沉着合并糖尿病、肝功能异常时,应考虑血色病可能,基因检测不仅可协助诊断血色病,还可以协助鉴别原发性和继发性血色病。 -
关键词:
- 糖尿病 /
- 铁过载 /
- X连锁铁粒幼细胞性贫血 /
- 血色病
Abstract:Objective To analyze and summarize case data of patients with X-linked sideroblastic anemia secondary to hematological diseases. Methods The clinical data of a case of X-linked sideroblastic anemia with secondary hemochromatosis admitted to the Department of Endocrinology of the First Affiliated Hospital of Kunming Medical University were retrospectively analyzed, and the related literatures were reviewed. Results The patient presented with persistent fatigue and sought medical attention at multiple hospitals, yet the underlying cause remained elusive. Subsequently, the patient was admitted to the Department of Endocrinology of the First Affiliated Hospital of Kunming Medical University due to hyperglycemia and cutaneous pigmentation. Following comprehensive diagnostic procedures including bone marrow aspiration, genetic testing, liver CT scan, and MRI examination, a definitive diagnosis was established. The patient’ s clinical symptoms exhibited improvement subsequent to iron chelation therapy. Later, the patient died of heart failure due to irregular iron treatment. Conclusion Diabetes caused by hemochromatosis is a special type of diabetes. Diagnosing this disease not only relies on serological and imaging examinations, but genetic testing is also very important. In clinical practice, when skin pigmentation combined with diabetes and liver function abnormalities are found, hemochromatosis should be considered. Genetic testing can not only assist in diagnosing hemochromatosis, but also help distinguish between primary and secondary hemochromatosis -
Key words:
- Diabetes /
- Iron overload /
- X-linked sideroblastic anemia /
- Hemochromatosis
-
表 1 与受检者临床表型高度相关的基因变异
Table 1. Genetic variations highly associated with the clinical phenotype of the subject
基因 染色体位置 转录本外显子 核苷酸氨基酸 纯合/
杂合正常人
频率预测致病性分析 遗传方式 疾病表型 ALAS2 chrX: 55042056 NM_000032-ex0n8 c.1123c>T
(p.R375C)hemi D Likely
Parlongenic1. XLR
2. XL1.铁粒幼细胞性贫血
2.X连锁原卟啉病hemi 表示此突变位点为半合子突变;D为预测有害;XLR表示X连锁隐性遗传。 -
[1] Cotter P D,Rucknagel D L,Bishop D F. X-linked sideroblastic anemia: Identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley[J]. Blood,1994,84(11):3915-3924. doi: 10.1182/blood.V84.11.3915.bloodjournal84113915 [2] 李丽,贾继东,王宝恩. 血色病的欧美诊断治疗规范[J]. 胃肠病学和肝病学杂志,2008,17(1): 1-3. [3] 赵和平,朱履刚,申纪轩,等. 早期肝血色素沉积症诊治体会(附病例报告1例)[J]. 实用医药杂志,2005,22(3): 1. [4] 杨坤,郭昆全,鱼强,等. 原发性血色病继发性糖尿病一例报告[J]. 中华内分泌代谢杂志,2007,23(1): 85-86. [5] Santos P C,Cancado R D,Pereira A C,et al. Hereditary hemochromatosis: Mutations in genes involved in iron homeostasis in Brazilian patients[J]. Blood Cells Mol Dis,2011,46(4):302-307. doi: 10.1016/j.bcmd.2011.02.008 [6] Bacon B R,Adams P C,Kowdley K V,et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American association for the study of liver diseases[J]. Hepatology,2011,54(1):328-343. doi: 10.1002/hep.24330 [7] Porter J L,Rawla P. Hemochromatosis[A]. In: StatPearls. Treasure Island (FL),2023. [8] Ono K,Fujiwara T,Saito K,et al. Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis[J]. Sci Rep,2022,12(1):9024. doi: 10.1038/s41598-022-12940-9 [9] Johnson-Wimbley T D,Graham D Y. Diagnosis and management of iron deficiency anemia in the 21st century[J]. Therapeutic Advances in Gastroenterology,2011,4(3):177-184. doi: 10.1177/1756283X11398736 [10] Mitchell M,Gore S D,Zeidan A M. Iron chelation therapy in myelodysplastic syndromes: Where do we stand?[J]. Expert Review of Hematology,2013,6(4):397-410. doi: 10.1586/17474086.2013.814456 [11] Raju K,Venkataramappa S M. Primary hemochromatosis presenting as type 2 diabetes mellitus: A case report with review of literature[J]. Int J Appl Basic Med Res,2018,8(1):57-60. doi: 10.4103/ijabmr.IJABMR_402_16 [12] Pelusi C,Gasparini D I,Bianchi N,et al. Endocrine dysfunction in hereditary hemochromatosis[J]. J Endocrinol Invest,2016,39(8):837-847. doi: 10.1007/s40618-016-0451-7 [13] Unlusoy Aksu A,Caleffi A,Pietrangelo A,et al. Iron overload in the liver of 2 children: Nonalcoholic steatohepatitis and juvenile hemochromatosis[J]. J Pediatr Hematol Oncol,2017,39(6):466-469. doi: 10.1097/MPH.0000000000000752 [14] Pawlotsky Y,Roussey M,Hany Y,et al. Increased blood parathormone levels in idiopathic hemochromatosis[J]. Nouv Presse Med,1974,3(28):1757-1758. [15] Udani K,Chris-Olaiya A,Ohadugha C,et al. Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States[J]. Int J Cardiol,2021,342:117-124. doi: 10.1016/j.ijcard.2021.07.060 [16] Nekrasova T P,Berestova A V. Value of liver biopsy in the diagnosis of hereditary hemochromatosis[J]. Arkh Patol,2019,81(1):35-39. doi: 10.17116/patol20198101135 [17] Hsu C C,Senussi N H,Fertrin K Y,et al. Iron overload disorders[J]. Hepatol Commun,2022,6(8):1842-1854. doi: 10.1002/hep4.2012 [18] Kowdley K V,Brown K E,Ahn J,et al. ACG clinical guideline: Hereditary hemochromatosis[J]. Am J Gastroenterol,2019,114(8):1202-1218. doi: 10.14309/ajg.0000000000000315 [19] 李菲菲,韩国庆,主余华,等. 肝硬化合并肝血色病诊治体会及经验[J]. 中华肝脏病杂志,2017,25(4):302-304. -